TGTX (TG Pharma) Operating Margin

Public company logo of TG Therapeutics Corp (TGTX)

TG Therapeutics, Inc. (TGTX) relies critically on the success of a single drug, which creates regulatory risks. The expansion of its portfolio of medications for multiple sclerosis and blood cancer mitigates these risks. The operating margin curve clearly confirms this trend, where the level of 21.50 is the current value. Stability is maintained by a streamlined production of antibodies at contract facilities with strict quality control.

TGTX: TG Therapeutics Operating Return on Sales 07/04/2022 - 11/20/2026

Analytical breakdowns and data insights for company tgtherapeutics.com (TGTX)

Summary company analytics:tgtherapeutics.com, TGTX
Finished products of TG Therapeutics, Inc.

Operating margin measures the share of profit from core business operations before taxes and interest expenses relative to revenue, serving as a barometer for cost management efficiency. By analyzing the operating margin time series, an investor assesses the resilience of TG Therapeutics, Inc. (TGTX) to market stress, taking into account capital expenditures for energy-efficient equipment and the environmental modernization of laboratories to comply with ESG standards.